DBK Pharmaceutical

DBK Pharmaceutical, established in 2005, is a prominent integrated pharmaceutical company headquartered in Egypt. Operating within the Healthcare and Pharmaceuticals sectors, the company is dedicated to enhancing quality of life through innovative medicines and a commitment to integrity and community health. DBK Pharmaceutical focuses on the development, manufacturing, and marketing of a diverse portfolio, including pharmaceutical products, herbal brands, cosmetics, food supplements, and veterinary products. Its extensive product range addresses critical therapeutic areas such as cardiovascular, gastrointestinal, musculoskeletal, anti-infective, respiratory, and dermatological conditions. With a workforce of 500 - 1,000 employees and an annual revenue of $44.5M, the company demonstrates significant operational scale and market presence. Meet DBK Pharmaceutical's team to learn more about their leadership and expertise.

The company strategically targets emerging markets and healthcare providers, emphasizing high-quality and affordable healthcare solutions. Its operational footprint, while centered in Egypt, is supported by hashtags indicating a broader reach, including #africa and #middleeast, reflecting its commitment to serving diverse patient populations. DBK Pharmaceutical's product development pipeline and manufacturing capabilities are geared towards meeting evolving healthcare needs, ensuring accessibility and efficacy across its offerings. The company's integrated approach allows for comprehensive control over product quality from research and development through to market distribution.

DBK Pharmaceutical's business model is built on a foundation of scientific rigor and market responsiveness. By leveraging its expertise in pharmaceutical sciences, it aims to deliver value to patients, healthcare professionals, and stakeholders alike. The company's dedication to innovation is evident in its continuous efforts to expand its product lines andView more...